Market Closed -
London S.E.
09:05:26 20/05/2024 pm IST
|
5-day change
|
1st Jan Change
|
10.75
GBX
|
0.00%
|
|
+5.39%
|
-2.27%
|
Fiscal Period: June |
2021
|
2022
|
2023
|
---|
Capitalization
1 |
138.1
|
33.87
|
36.95
|
Enterprise Value (EV)
1 |
134.7
|
32.76
|
34.74
|
P/E ratio
|
-19.5
x
|
-1.57
x
|
-10.5
x
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
11.9
x
|
11.9
x
|
9.14
x
|
EV / Revenue
|
11.6
x
|
11.6
x
|
8.59
x
|
EV / EBITDA
|
-27.2
x
|
-3.09
x
|
-11.7
x
|
EV / FCF
|
-79,83,918
x
|
-1,43,87,586
x
|
1,53,58,466
x
|
FCF Yield
|
-0%
|
-0%
|
0%
|
Price to Book
|
6.39
x
|
5.2
x
|
12.1
x
|
Nbr of stocks (in thousands)
|
2,81,932
|
3,07,945
|
3,07,950
|
Reference price
2 |
0.4900
|
0.1100
|
0.1200
|
Announcement Date
|
29/11/21
|
24/11/22
|
17/10/23
|
Fiscal Period: June |
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
5.235
|
11.62
|
2.835
|
4.045
|
EBITDA
1 |
0.278
|
-4.942
|
-10.59
|
-2.966
|
EBIT
1 |
0.217
|
-5.372
|
-11.86
|
-3.594
|
Operating Margin
|
4.15%
|
-46.24%
|
-418.52%
|
-88.85%
|
Earnings before Tax (EBT)
1 |
-3.375
|
-6.954
|
-21.59
|
-3.556
|
Net income
1 |
-3.374
|
-6.973
|
-21.26
|
-3.451
|
Net margin
|
-64.45%
|
-60.02%
|
-749.98%
|
-85.32%
|
EPS
|
-
|
-0.0251
|
-0.0699
|
-0.0114
|
Free Cash Flow
|
-
|
-16.87
|
-2.277
|
2.262
|
FCF margin
|
-
|
-145.18%
|
-80.31%
|
55.91%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
Announcement Date
|
29/11/21
|
29/11/21
|
24/11/22
|
17/10/23
|
Fiscal Period: June |
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
0.38
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
3.48
|
1.12
|
2.22
|
Leverage (Debt/EBITDA)
|
1.381
x
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-16.9
|
-2.28
|
2.26
|
ROE (net income / shareholders' equity)
|
-
|
-57.9%
|
-153%
|
-73.1%
|
ROA (Net income/ Total Assets)
|
-
|
-15.2%
|
-32.2%
|
-23.9%
|
Assets
1 |
-
|
45.89
|
65.94
|
14.47
|
Book Value Per Share
|
-
|
0.0800
|
0.0200
|
0.0100
|
Cash Flow per Share
|
-
|
0.0200
|
0.0100
|
0.0100
|
Capex
1 |
1.65
|
6.76
|
0.68
|
0.08
|
Capex / Sales
|
31.52%
|
58.19%
|
24.06%
|
1.85%
|
Announcement Date
|
29/11/21
|
29/11/21
|
24/11/22
|
17/10/23
|
|
1st Jan change
|
Capi.
|
---|
| -2.27% | 42.75M | | -5.27% | 12.32B | | -3.86% | 8.07B | | +33.66% | 5.52B | | -7.35% | 4.21B | | -55.63% | 2.99B | | +13.62% | 2.73B | | -3.65% | 2.43B | | +30.67% | 2.29B | | -4.31% | 1.89B |
Diagnostic & Testing Substances
|